Rehabilitation management of neuromuscular disease: The role of exercise training

Journal of Clinical Neuromuscular Disease

Volumn 11, Issue 1, 2009, Pages 7-21

  Abresch, R Ted ^a   Han, Jay J ^a   Carter, Gregory T ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Exercise; Muscular dystrophy; Neuromuscular disease; Rehabilitation; Strength training

Indexed keywords

DYSTROPHIN; NEURONAL NITRIC OXIDE SYNTHASE;

AEROBIC CAPACITY; AEROBIC EXERCISE; ALPHA SARCOGLYCAN ADHALIN; AMYOTROPHIC LATERAL SCLEROSIS; BECKER MUSCULAR DYSTROPHY; CALPAINOPATHY; DUCHENNE MUSCULAR DYSTROPHY; DYSFERLINOPATHY; EXERCISE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GAMMA SARCOGLYCANOPATHY; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 5; HEART MUSCLE; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MITOCHONDRIAL MYOPATHY; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MUSCLE TRAINING; MUSCULAR DYSTROPHY; MYOGLOBINURIA; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR SYSTEM; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PATIENT SELECTION; PHYSICAL FITNESS; RISK ASSESSMENT;

EID: 70349086559     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181a8d36b     Document Type: Review

References (125)

1. Pate RR, Pratt M, Blair SN, et al. Physical activity andpublic health. A recommendation from the Centersfor Disease Control and Prevention and theAmerican College of Sports Medicine. JAMA. 1995;273:402-407.
2. Zinna EM, Yarasheski KE. Exercise treatment tocounteract protein wasting of chronic diseases.Curr Opin Clin Nutr Metab Care. 2003;6:87-93.
3. Grutel M. The sarcomere and the nucleus:functional links to hypertrophy, atrophy and sarcopenia. Adv Exp Med Biol. 2008;642:176-191.
4. Favier FB, Benoit H, Freyssenet D. Cellular andmolecular events controlling skeletal muscle massin response to altered use. P flugers Arch. 2008;456:587-600.
5. Fowler WM Jr, Taylor M. Rehabilitation managementof muscular dystrophy and related disorders: I. Therole of exercise. Arch Phys Med Rehabil. 1982;63:319-321.
6. Vignos PJ Jr. Rehabilitation in the myopathies. In:Vinken PJ, Bruyn GW, eds. Handbook of clinicalneurology. Amsterdam: North Holland Publishing,1980:457-500.
7. Johnson EW, Braddom R: Over-work weakness infacioscapulohumeral dystrophy. Arch Phys Med Rehabil. 1971;52:333-362
8. Bennett RL, Knowlton GC. Overwork weakness inpartially denervated skeletal muscle. Clin Orthop1958;12:22-92.
9. Aitkens S, Kilmer DD, Wright NC, et al. Metabolicsyndrome in neuromuscular disease.Med Rehabil. 2005;86:1030-1036.
10. Miller TD, Balady GJ, Fletcher GF. Exercise andits role in the prevention and rehabilitation ofcardiovascular disease. Ann Behav Med220-229.
11. Fowler WM Jr. Role of physical activity and exercisetraining in neuromuscular diseases.Rehabil. 2002;81:S187-S195.
12. Milner-Brown HS, Miller RG. Muscle strengtheningthrough high-resistance weight training in patientswith neuromuscular disorders. Arch Phys Med Rehabil. 1988;69:14-19.
13. McCartney N, Moroz D, Garner SH, et al. The effectsof strength training in patients with selectedneuromuscular disorders. Med Sci Sports Exerc1988;20:362-368.
14. Aitkens SG, McCrory MA, Kilmer DD, et al.Moderate resistance exercise program: its effectin slowly progressive neuromuscular disease.Phys Med Rehabil. 1993;74:711-715.
15. Kilmer DD, McCrory MA, Wright NC. The effect ofa high resistance exercise program in slowlyprogressive neuromuscular disease.Med Rehabil. 1994;75:560-563.
16. Florence JM, Hagberg JM. Effect of training on theexercise responses of neuromuscular diseasepatients. Med Sci Sports Exerc. 1984;16:460-465.
17. Wright NC, Kilmer DD, McCrory MA, et al. Aerobicwalking in slowly progressive neuromuscular disease:effect of a 12-week program.Rehabil. 1996;77:64-69.
18. Kilmer DD, Aitkens S, Wright NC, et al. Response tohigh-intensity eccentric muscle contractions inpersons with myopathic disease.2001;24:1181- 1187.
19. Dal Bello-Haas V, Florence JM, Krivickas LS.Therapeutic exercise for people with amyotrophiclateral sclerosis or motor neuron disease.Cochrane Database Syst Rev. 2008;Issue 2. Art.No.: CD005229.
20. van der Kooi EL, Lindeman E, Riphagen I. Strengthtraining and aerobic exercise training for muscledisease. Cochrane Database Syst RevCD003907.
21. White CM, Pritchard J, Turner-Stokes L. Exercisefor people with peripheral neuropathy.Database Syst Rev. 2004;Issue 4. Art. No.:CD003904.
22. Cup EH, Pieterse AJ, Ten Broek-Pastoor JM, et al.Exercise therapy and other types of physicaltherapy for patients with neuromuscular diseases:a systematic review. Arch Phys Med Rehabil88:1452-1464.
23. Ervasti JM. A role for the dystrophin-glycoproteincomplex as a transmembrane linker betweenlaminin and actin. J Cell Biol809-823.
24. Franco A Jr, Lansman JB. Calcium entry throughstretch-inactivated ion channels in mdx myotubes.Nature. 1990;344:670-673.
25. Turner PR, Fong PY, Denetclaw WF, et al. Increasedcalcium influx in dystrophic muscle. J Cell Biol.1991;115:1701-1712.
26. Stedman HH, Sweeney HL, Shrager JB, et al. Themdx mouse diaphragm reproduces the degenerativechanges of Duchenne muscular dystrophy.Nature. 1991;352:536-539.
27. Clarkson PM, Nosaka K, Braun B. Muscle functionafter exercise-induced muscle damage and rapidadaptation. Med Sci Sports Exerc. 1992;24:512-520.
28. Friden J, Lieber RL. Structural and mechanical basisof exercise-induced muscle injury. Med Sci Sports Exerc. 1992;24:521-530.
29. McDonald CM, Abresch RT, Carter GT, et al. Profilesof neuromuscular diseases: Duchenne musculardystrophy. Am J Phys Med Rehabil. 1995;74:S70-S92.
30. Pasternak C, Wong S, Elson EL. Mechanical functionof dystrophin in muscle cells. J Cell Biol. 1995;128:355-361.
31. Petrof BJ, Shrager JB, Stedman HH, et al. Dystrophinprotects the sarcolemma from stresses developedduring muscle contraction. Proc Natl Acad Sci USA.1993;90:3710-3714.
32. Sander M, Chavoshan B, Harris S, et al. Functionalmuscle ischemia in neuronal nitric oxide synthasedeficientskeletal muscle of children with Duchennemuscular dystrophy. Proc Natl Acad SciUSA. 2000;97:13818-13823.
33. Kobayashi YM, Rader EP, Crawford RW, et al.Sarcolemma-localized nNOS is required to maintainactivity after mild exercise. Nature. 2008;456:511-515.
34. Vignos PJ Jr, Watkins MP. Effect of exercise inmuscular dystrophy. JAMA. 1966;197:843-848.
35. Dubowitz V, Hyde SA, Scott OM, et al. Controlledtrial of exercise in Duchenne muscular dystrophy.In: Serratrice G, editor. Neuromuscular Diseases.New York: Raven Press, 1984:571-575.
36. DeLateur BJ, Giaconi RM. Effect on maximalstrength of submaximal exercise in Duchennemuscular dystrophy. Am J Phys Med. 1979;58:26-36.
37. Scott OM, Hyde SA, Goddard C, et al. Effect ofexercise in Duchenne muscular dystrophy: controlledsix-month feasibility study of effects of twodifferent regimes of exercises in children withDuchenne dystrophy. Physiotherapy. 1981;67:174-176.
38. Garrood M, Eagle P. Jardine, et al. Myoglobinuriain boys with Duchenne muscular dystrophy on corticosteroid therapy. Neuromuscul Disord. 2008;18:71-73.
39. Kimura S, Ikezawa M, Nomura K, et al. Immobilityreduces muscle fiber necrosis in dystrophin deficientmuscular dystrophy. Brain Dev. 2006;28:473-476.
40. Vilozni D, Bar-Yishay E, Gur I, et al. Computerizedrespiratory muscle training in children with Duchennemuscular dystrophy. Neuromuscul Disord.1994;4:249-255.
41. Wanke T, Toifl K, Merkle M, et al. Inspiratory muscle training in patients with Duchenne musculardystrophy. Chest. 1994;105:475-482.
42. Koessler W, Wanke T, Winkler G, et al. 2 years'experience with inspiratory muscle training inpatients with neuromuscular disorders. Chest.2001;120:765-769.
43. Martin AJ, Stern L, Yeates J, et al. Respiratory muscletraining in Duchenne muscular dystrophy. Dev Med Child Neurol. 1986;28:314-318.
44. Gozal D, Thiriet P. Respiratory muscle training inneuromuscular disease: long-term effects onstrength and load perception. Med Sci Sports Exerc. 1999;31:1522-1527.
45. Rodillo E, Noble-Jamieson CM, Aber V, et al.Respiratory muscle training in Duchenne musculardystrophy. Arch Dis Child. 1989;64:736-738.
46. Stern LM, Martin AJ, Jones N, et al. Traininginspiratory resistance in Duchenne dystrophyusing adapted computer games. Dev Med Child Neurol. 1989;31:494-500.
47. Smith PEM, Calverley PMA, Edwards RHT, et al.Practical considerations of respiratory care ofpatients with muscular dystrophy. N Engl J Med.1987;316:1197-1205.
48. Sveen ML, Jeppesen TD, Hauerslev S, et al.Endurance training improves fitness and strengthin patients with Becker muscular dystrophy.Brain. 2008;131:2824-2831.
49. Mathews KD, Moore SA. Limb girdle muscular dystrophy.Curr Neurol Neurosci Rep. 2003:3:78-85.
50. Moore SA, Shilling CJ, Westra S, et al. Limb girdlemuscular dystrophy in the United States.J Neuropathol Exp Neurol. 2006;65:995-1003.
51. Sveen ML, Jeppesen TD, Hauerslev S, et al. Endurancetraining: an effective and safe treatment forpatients with LGMD2I. Neurology. 2007;68:59-61.
52. Yeldan I, Gurses HN, Yuksel H. Comparison study ofchest physiotherapy home training programmes onrespiratory functions in patients with musculardystrophy. Clin Rehabil. 2008;22:741-748.
53. Böhme P, Arnold C. Limb-girdle muscular dystrophy-results of physical therapy under stationary conditions.Aktuelle Neurol. 2004;1:1-5.
54. Ansved T. Muscular dystrophies: influence ofphysical conditioning on the disease evolution. CurrOpin Clin Nutr Metab Care. 2003;6:435-439.
55. Wijmenga C, Frants RR, Hewitt JE, et al. Moleculargenetics of facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 1993;3:487-491.
56. Tawil R. Facioscapulohumeral muscular dystrophy.Neurotherapeutics. 2008;5:601-606.
57. Karpati G, Molnar N. Muscle fibre regeneration inhuman skeletal muscle diseases. In: Schiaffino S,Partridge T, eds. Skeletal Muscle Repair and Regeneration. Netherlands: Springer Science 2008:199-216.
58. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al.Strength training and albuterol in facioscapulohumeralmuscular dystrophy. Neurology. 2004;63:702-708.
59. Lindeman E, Drukker J. Specificity of strengthtraining in neuromuscular disorders. J Rehabil Sci.1994;7:13-15.
60. Olsen DB, Orngreen MC, Vissing J. Aerobic trainingimproves exercise performance in facioscapulohumeralmuscular dystrophy. Neurology. 2005;64:1064-1066.
61. Harley H, Rundle SA, MacMillan JC, et al. Size of theunstable CTG repeat sequence in relation tophenotype and parental transmission in myotonicdystrophy. Am J. Hum Genet. 1993;52:1164-1174.
62. Hunter A, Tsilfidis C, Mettler G, et al. Thecorrelation of age of onset with CTG trinucleotiderepeat amplification in myotonic dystrophy. J MedGenet. 1992;29:774-779.
63. Bachinski LL, Udd B, Meola G, et al. Confirmation ofthe type 2 myotonic dystrophy (CCTG)n expansionmutation in patients with proximal myotonicmyopathy/proximal myotonic dystrophy of differentEuropean origins: a single shared haplotypeindicates an ancestral founder effect. Am J Hum Genet. 2003:73:835-848.
64. Mahadevan MS, Yadava RS, Yu Q, et al. Reversiblemodel of RNA toxicity and cardiac conductiondefects in myotonic dystrophy. Nat Genet. 2006;38:1066-1070.
65. Lindeman E, Leffers P, Spaans F, et al. Strengthtraining in patients with myotonic dystrophy andhereditary motor and sensory neuropathy: a randomizedclinical trial. Arch Phys Med Rehabil.1995;76:612-620.
66. Tollback A, Eriksson S, Wredenberg A, et al. Effectsof high-resistance training in patients withmyotonic dystrophy. Scand J Rehab Med. 1999;31:9-16.
67. Aldehag AS, Jonsson H, Ansved T. Effects of a handtraining programme in five patients with myotonicdystrophy type 1. Occup Ther Int. 2005;12:14-27.
68. Wenneberg S, Gunnarsson LG, Ahlström G. Usinga novel exercise programme for patients withmuscular dystrophy. Part I: a qualitative study.Disabil Rehabil. 2004;26:586-594. (Pubitemid 38771875)
69. Orngreen MC, Olsen DB, Vissing J. Aerobic trainingin patients with myotonic dystrophy type I. Ann Neurol. 2005;57:754-757.
70. Haller RG, Wyrick P, Taivassalo T, et al. Aerobicconditioning: an effective therapy in McArdle'sdisease. Ann Neurol. 2006;59:922-928.
71. Maté-Muñoz JL, Moran M, Pérez M, et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med. 2007;17:297-303.
72. Pérez M, Foster C, González-Freire M, et al. One-year follow-up in a child with McArdle disease: exerciseis medicine. Pediatr Neurol. 2008;38:133-136.
73. Pérez M, Maté-Muñoz JL, Foster C, et al. Exercisecapacity in a child with McArdle disease. J Child Neurol. 2007;22:880-882.
74. Ollivier K, Hogrel JY, Gomez-Merino D, et al.Exercise tolerance and daily life in McArdle's disease. Muscle Nerve. 2005;31:637-641
75. Taivassalo T, Matthews PM, De Stefano N, et al.Combined aerobic training and dichloroacetateimprove exercise capacity and indices of aerobicmetabolism in muscle cytochrome oxidase deficiency.Neurology. 1996;47:529-534.
76. Taivassalo T, De Stefano N, Argov Z, et al. Effects of aerobic training in patients with mitochondrial myopathies. Neurology. 1998:50:1055-1060.
77. Taivassalo T, De Stefano N, Chen J, et al. Short-termaerobic training response in chronic myopathies.Muscle Nerve. 1999;22:1239-1243.
78. Taivassalo T, Shoubridge EA, Chen J, et al. Aerobicconditioning in patients with mitochondrial myopathies:physiological, biochemical, and geneticeffects. Ann Neurol. 2001;50:133-141.
79. Taivassalo T, Haller RG. Exercise and training inmitochondrial myopathies. Med Sci Sports Exerc2005;37:2094-2101.
80. Taivassalo T, Gardner JL, Taylor RW, et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions.Brain. 2006;129(Pt 12):3391-3401.
81. Murphy JL, Blakely EL, Schaefer AM, et al. Resistancetraining in patients with single, large-scaledeletions of mitochondrial DNA. Brain2832-2840.
82. Siciliano G, Manca ML, Renna M, et al. Effects ofaerobic training on lactate and catecholaminergicexercise responses in mitochondrial myopathies,Neuromuscul Disord. 2000;10:40-45.
83. Jeppesen TD, Schwartz M, Olsen DB, et al. Aerobictraining is safe and improves exercise capacity inpatients with mitochondrial myopathy.2006;129:3402- 3412.
84. Cejudo P, Bautista J, and Montemayor T, et al.Exercise training in mitochondrial myopathy:a randomized controlled trial.2005;32:342-350.
85. Trenell MI, Sue CM, Kemp GJ, et al. Aerobicexercise and muscle metabolism in patients withmitochondrial myopathy. Muscle Nerve524-531.
86. Askanas V, Engel WK. Inclusion body myositis,a multifactorial muscle disease associated withaging: current concepts of pathogenesis.Opin Rheumatol. 2007;19:550-559.
87. Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients withpolymyositis and dermatomyositis: a pilot study.Rheumatology. 1999;38:608-611.
88. Alexanderson H, Stenstrom CH, Jenner G, et al. The safety of a resistive home exercise program inpatients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol295-301.
89. Alexanderson H, Lundberg IE. The role of exercisein the rehabilitation of idiopathic inflammatory myopathies.Curr Opin Rheumatol. 2005;17:164-171.
90. Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M,et al. Benefits of intensive resistance training inpatients with chronic polymyositis or dermatomyositis.Arthritis Rheum. 2007;57:766-777.
91. Wiesinger GF, Quittan M, Graninger M, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.tol. 1988;37:338-1342.
92. Wiesinger GF, Quittan M, Nuhr M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil. 2000;81:1-5.
93. Hicks JE, Drinkard B, Summers RM, et al. Decreased aerobic capacity in children with juvenile dermatomyositis.Arthritis Rheum. 2002;15:118-123.
94. Arnardottir S, Alexanderson H, Lundberg IE, et al.Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction.J Rehabil Med. 2003;35:31-35.
95. Rosen DR, Siddique T, Patterson D, et al. Mutationsin Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature.1993;362:59-62.
96. Kaspar BK, Frost LM, Christian L, et al. Synergy of insulin-like growth factor-1 and exercise in amyotrophiclateral sclerosis. Ann Neurol. 2005;57:649-655.
97. Kirkinezos IG, Hernandez D, Bradley WG, et al.Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003;53:804-807.
98. Veldink JH, Bär PR, Joosten EA, et al. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737-743.
99. Liebetanz D, Hagemann K, von Lewinski F, et al.Extensive exercise is not harmful in amyotrophiclateral sclerosis. Eur J Neurosci. 2004;20:3115-3120.
100. Mahoney DJ, Rodriguez C, Devries M, et al. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.Muscle Nerve. 2004;29:656-662.
101. McCrate ME, Kaspar BK. Physical activity and neuro protection in amyotrophic lateral sclerosis.Neuromolecular Med. 2008;10:108-117.
102. Bello-Haas VD, Florence JM, Kloos AD, et al. Arandomized controlled trial of resistance exercisein individuals with ALS. Neurology. 2007;68:2003-2007.
103. Drory VE, Goltsman E, Reznik JG, et al. The value of muscle exercise in patients with amyotrophiclateral sclerosis. J Neurol Sci. 2001;191:133-137.
104. Halsted LS, Rossi CD. New problems in old polio patients: results of a survey of 530 polio survivors.Orthopedics. 1985:8:845-850.
105. Halstead LS, Gawne AC, Pham BT. National rehabilitation hospital limb classification for exercise,research, and clinical trials in post-polio patients. Ann N Y Acad Sci. 1995;753:343-353.
106. March of Dimes. March of Dimes International Conference on Post Polio Syndrome. Identifying Best Practices in Diagnosis and Care. WhitePlains, NY: March of Dimes 2000.
107. Farbu E, Gilhus NE, Barnes MP, et al. EFNS guidelineon diagnosis and management of post-polio syndrome.Report of an EFNS task force. Eur J Neurol.2006;13:795-1780
108. Chan KM, Amirjani N, Sumrain M, et al. Randomized controlled trial of strength training in post-poliopatients. Muscle Nerve. 2003;27:332-338.
109. Klein MG, Whyte J, Esquenazi A, et al. A comparisonof the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study.Arch Physical Med Rehabil. 2002;83:708-713.
110. Prins JH, Hartung HD, Merritt DJ, et al. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Training Rehabil. 1994;5:29-39.
111. Agre JC, Rodriquez AA, Franke TM, et al. Lowintensity,alternate-day exercise improves muscle performance without apparent adverse affect inpostpolio patients. Am J Phys Med Rehabil. 1996;78:50-62.
112. Agre JC, Rodriquez AA, Franke TM. Strength,endurance, and work capacity after muscle strengthening exercise in postpolio subjects. ArchPhys Med Rehabil. 1997;78:681-686.
113. Einarsson G. Muscle conditioning in late poliomyelitis.Arch Phys Med Rehabil. 1991;72:11-14.
114. Fillyaw MJ, Badger GJ, Goodwin GD, et al. The effects of long-term non-fatiguing resistance exercisein subjects with post-polio syndrome. Orthopedics.1991;14:1253-1256.
115. Spector SA, Gordon PL, Feuerstein IM, et al.Strength gains without muscle injury after strengthtraining in patients with postpolio muscularatrophy. Muscle Nerve. 1996;19:1282-1290.
116. Jones DR, Speier J, Canine K, et al. Cardio respiratory responses to aerobic training by patients with post poliomyelitis sequelae. JAMA. 1989;9;261:3255-3258.
117. Willén C, Sunnerhagen KS, Grimby G. Dynamic water exercise in individuals with late poliomyelitis.Arch Phys Med Rehabil. 2001;82:66-72.
118. Ernstoff B, Wetterqvist H, Kvist H, et al. Endurance training effect on individuals with post poliomyelitis.Arch Phys Med Rehabil. 1996;77:843-848.
119. Kriz JL, Jones DR, Speier JL, et al. Cardio respiratory responses to upper extremity aerobic training by post polio subjects. Arch Phys Med Rehabil. 1992;73:49-54.
120. Dean E, Ross J. Effect of modified aerobic trainingon movement energetics in polio survivors. Orthopedics.1991;14:1243-1246.
121. Jani-Acsadi A, Krajewski K, et al. Charcot-Marie-Tooth neuropathies: diagnosis and management.Semin Neurol. 2008;28:185-194.
122. Shy ME, Chen L, Swan ER, et al. Neuropathy progression in Charcot-Marie-Tooth disease type1A. Neurology. 2008;70:378-383.
123. Chetlin RD, Gutmann L, Tarnopolsky M, et al.Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil.2004;85:1217-1223.
124. El Mhandi L, Millet GY, Calmels P, et al. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve.2008;37:601-610.
125. Grange RW, Call JA. Recommendations to defineexercise prescription for Duchenne muscular dystrophy. Exerc Sport Sci Rev. 2007;35:12-17.